Search

everythinglearnresearchcommunity

for

Search:↓

Urinary PSA could be an early marker for enlarged prostate.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Red ginseng oil improves urinary symptoms and some sexual functions in men safely.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Early balding may be a sign of future prostate problems.

Early hair loss may indicate future prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.